home / stock / avhhl / avhhl news


AVHHL News and Press, Avita Therapeutics

Stock Information

Company Name: Avita Therapeutics
Stock Symbol: AVHHL
Market: OTC
Website: avitamedical.com

Menu

AVHHL AVHHL Quote AVHHL Short AVHHL News AVHHL Articles AVHHL Message Board
Get AVHHL Alerts

News, Short Squeeze, Breakout and More Instantly...

AVHHL - AVITA Medical to participate at the TD Cowen 46th Annual Health Care Conference

VALENCIA, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- AVITA Medical ® , Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound care company delivering transformative solutions, today announced Cary Vance, Interim CEO, and David O’Toole, CFO, will be participating in the upcomi...

AVHHL - AVITA Medical, Inc. (RCEL) Discusses Financial Performance, Sales Strategy, and Reimbursement Progress Transcript

2026-02-19 03:44:56 ET AVITA Medical, Inc. (RCEL) Discusses Financial Performance, Sales Strategy, and Reimbursement Progress February 18, 2026 5:00 PM EST... Read the full article on Seeking Alpha For further details see: AVITA Medical, Inc. (RCEL) Discusses Financial Perfo...

AVHHL - Avita Medical GAAP EPS of -$0.38, revenue of $17.6M

2026-02-13 12:06:14 ET More on AVITA Medical AVITA Medical, Inc. (RCEL) Q4 2025 Earnings Call Transcript AVITA Medical, Inc. 2025 Q4 - Results - Earnings Call Presentation Avita Medical: Set Up For A Turnaround Avita Medical outlines 2026 revenue target of $8...

AVHHL - Avita Medical outlines 2026 revenue target of $80M-$85M as reimbursement clarity supports multiproduct utilization

2026-02-12 20:15:14 ET More on AVITA Medical AVITA Medical, Inc. (RCEL) Q4 2025 Earnings Call Transcript AVITA Medical, Inc. 2025 Q4 - Results - Earnings Call Presentation Avita Medical: Set Up For A Turnaround AVITA Medical GAAP EPS of -$0.38 beats by $0.02,...

AVHHL - AVITA Medical, Inc. (RCEL) Q4 2025 Earnings Call Transcript

2026-02-12 20:14:25 ET AVITA Medical, Inc. (RCEL) Q4 2025 Earnings Call February 12, 2026 4:30 PM EST Company Participants Ben Atkins - Vice President of Investor Relations & Corporate Communications Cary Vance - Independent Non-Executive Chairman & Interim CEO ...

AVHHL - AVITA Medical Reports Fourth Quarter and Full Year 2025 Financial Results

VALENCIA, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- AVITA Medical ® , Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions (“AVITA Medical,” or the “Company”), today reported financial results for the fo...

AVHHL - Data at 2026 Boswick Burn & Wound Symposium highlight first integrated use of AVITA Medical technologies

First surgeon-reported case using RECELL ® , PermeaDerm ® , and Cohealyx ™ together in a single care pathway New clinical and tissue-level data on PermeaDerm and Cohealyx highlight wound bed preparation and readiness for closure RECELL analyses show consist...

AVHHL - AVITA Medical, Inc. (RCEL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

2026-01-14 23:25:58 ET AVITA Medical, Inc. (RCEL) 44th Annual J.P. Morgan Healthcare Conference January 14, 2026 8:15 PM EST... Read the full article on Seeking Alpha For further details see: AVITA Medical, Inc. (RCEL) Presents at 44th Annual J.P. Morgan Healthcare Conferenc...

AVHHL - AVITA Medical: Pre-J.P. Morgan Update Highlights 2025 Revenue Growth, New Debt Facility, and 2026 Growth Outlook

VALENCIA, Calif., Jan. 13, 2026 (GLOBE NEWSWIRE) -- AVITA Medical ® , Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound care company delivering transformative solutions, today announced unaudited preliminary financial results and a business update for the fourth quarter and fi...

AVHHL - AVITA Medical Announces Changes to its Board of Directors

Veteran healthcare executive Joe Woody joins the Board Lou Panaccio retires after over a decade of service VALENCIA, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- AVITA Medical ® , Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound care company delivering transformative solu...

Next 10